Physician profile
Aman Amanullah
NPI 1255392023
$2,535.06
in general payments reported to CMS, 2019-2025
17 companies · $330 in 2025
The $330 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,781 · 2020: $43.41 · 2021: $125 · 2022: $93.84 · 2023: $141 · 2024: $20.92 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $491.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $1,144.15 | 2019 | |
| Sanofi-Aventis U.S. LLC | $500.00 | 2019 | |
| Edwards Lifesciences Corporation | $168.00 | 2025 | |
| Amgen INC. | $133.58 | 2019-2021 | |
| Pfizer INC. | $113.07 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $74.25 | 2023-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $74.04 | 2021-2023 | Verquvo |
| Janssen Pharmaceuticals, INC | $71.87 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $54.34 | 2022-2025 | Eliquis, Camzyos |
| Abbott Laboratories | $45.33 | 2019-2025 | Cardiomems |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.09 | 2021-2023 | Jardiance |
| Lantheus Medical Imaging, INC. | $31.76 | 2020-2021 | |
| Impulse Dynamics (USA) INC. | $24.07 | 2023 | Optimizer |
| Heartflow, INC. | $22.05 | 2025 | |
| Alexion Pharmaceuticals, INC. | $19.81 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $13.71 | 2023 | Farxiga |
| Altathera Pharmaceuticals LLC | $10.94 | 2023 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aman Amanullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.